← Back to Search

Sleep Questionnaire Validation for Down Syndrome

N/A
Waitlist Available
Led By Derek Lam, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ahi collected at initial sleep study and 3 months later (if a second sleep study is needed as determined by doctor)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether a questionnaire can accurately identify sleep apnea in children with Down syndrome.

Who is the study for?
This trial is for children with Down syndrome aged 2-17 years who visit the Down syndrome clinic at OHSU/Doernbecher's. They must have had a recent sleep study or be scheduled for one, and their caregivers need to read English or Spanish. Kids with tracheostomy, airway narrowing, or severe heart/lung disease needing extra oxygen can't join.
What is being tested?
The study aims to validate sleep questionnaires used in pediatric patients with Down syndrome by comparing questionnaire results with actual sleep studies. This helps understand the impact of obstructive sleep apnea on these kids' lives and check how well treatments are working.
What are the potential side effects?
Since this trial involves answering questionnaires related to sleep patterns and quality, there are no direct physical side effects from participating in this research.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ahi collected at initial sleep study and 3 months later (if a second sleep study is needed as determined by doctor)
This trial's timeline: 3 weeks for screening, Varies for treatment, and ahi collected at initial sleep study and 3 months later (if a second sleep study is needed as determined by doctor) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Apnea-hypopnea index (AHI) from polysomnography
Secondary study objectives
Generic Quality of Life
Sleep Related Breathing Disorder subscale total of the Pediatric Sleep Questionnaire (SRBD-PSQ)
Sleep-Related Quality of Life (OSA-18 total score)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Questionnaires and sleep studiesExperimental Treatment1 Intervention
Caregivers of patients meeting eligibility criteria will be invited to participate. If they agree to participate, baseline SRBD-PSQ, OSA-18, and PedsQL questionnaires along with written informed consent forms will be mailed to them along with their standard scheduling paperwork. Caregivers will be asked to review the consent form and complete the questionnaires and bring the paperwork to clinic on the day of their visit. Sleep study testing will also be ordered prior to their visit so that it can be scheduled within a month of the initial clinic visit and again three months later.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
1,006 Previous Clinical Trials
7,413,891 Total Patients Enrolled
4 Trials studying Down Syndrome
359 Patients Enrolled for Down Syndrome
Derek Lam, MD1.01 ReviewsPrincipal Investigator - Oregon Health and Science University
Oregon Health and Science University
1 Previous Clinical Trials
240 Total Patients Enrolled
1Patient Review
We were incredibly disappointed by Dr. Lam. He was cocky and failed to deliver on the care he promised our RARE, medically fragile child. We're grateful to the PICU team for stepping in when they did. If you choose to use Dr. Lam, don't expect him to be around when you need him most. You'll be left in the hands of residents. And his pain management skills were terrible.

Media Library

Sleep study Clinical Trial Eligibility Overview. Trial Name: NCT03771469 — N/A
Down Syndrome Research Study Groups: Questionnaires and sleep studies
Down Syndrome Clinical Trial 2023: Sleep study Highlights & Side Effects. Trial Name: NCT03771469 — N/A
Sleep study 2023 Treatment Timeline for Medical Study. Trial Name: NCT03771469 — N/A
~11 spots leftby Nov 2025